Insights2020-09-02T12:26:06+00:00

Insights

Our specialist team here at JensonR+ is experienced in regulatory affairs, product development, quality assurance, drug safety, medical information, copy approval, project management, training and market access.

Here we share insights into our ways of thinking in this changing landscape. Any questions please talk to us, we are happy to start the conversation.

Post BREXIT

By |January 7th, 2021|

With the transition period between the UK and EU now complete, the MHRA has published their guidance for pharmaceutical and device companies. At JensonR+ we can help support you with any Brexit related changes, with services ranging from Consultancy Advice to implementing and managing Quality Management Systems.

Load More Posts

Ready to start? Let’s work together!

CONTACT US